APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hib Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Hib Vaccine Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchHib Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Hib Vaccine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Hib Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hib Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Hib Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Hib Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Hib Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Hib Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Hib Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Hib Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Hib Vaccine include Lanzhou Institute, Zhifei Bio, Sanofi Pasteur, Kangtai Bio, Watson Bio, Glaxosmithkline, Olin Bio and Bharat Biotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Hib Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hib Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Hib Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hib Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hib Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Hib Vaccine sales, projected growth trends, production technology, application and end-user industry.

Hib Vaccine Segment by Company

Lanzhou Institute

Zhifei Bio

Sanofi Pasteur

Kangtai Bio

Watson Bio

Glaxosmithkline

Olin Bio

Bharat Biotech

Hib Vaccine Segment by Type

Hib Vaccine

Multiple Seedlings

Hib Vaccine Segment by Application

Hospital

Clinic

Hib Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hib Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hib Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hib Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Hib Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Hib Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hib Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hib Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hib Vaccine Major Manufacturers Table 3. Multiple Seedlings Major Manufacturers Table 4. Global Hib Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Hib Vaccine Industry Trends Table 8. Hib Vaccine Industry Drivers Table 9. Hib Vaccine Industry Opportunities and Challenges Table 10. Hib Vaccine Industry Restraints Table 11. Global Hib Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Hib Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Hib Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Hib Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Hib Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Hib Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Hib Vaccine Sales by Region (2021-2026) & (k units) Table 18. Global Hib Vaccine Sales by Region (2027-2032) & (k units) Table 19. Global Hib Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Hib Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Hib Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Hib Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Hib Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Hib Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Hib Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Hib Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Hib Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Hib Vaccine Manufacturers, Product Type & Application Table 29. Global Hib Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Hib Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Hib Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Hib Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Hib Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Hib Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Hib Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Hib Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Hib Vaccine Sales by Type (2021-2026) & (k units) Table 39. Global Hib Vaccine Sales by Type (2027-2032) & (k units) Table 40. Global Hib Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Hib Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Hib Vaccine Price by Type (2021-2026) & (US$/unit) Table 43. Global Hib Vaccine Price by Type (2027-2032) & (US$/unit) Table 44. Global Hib Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Hib Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Hib Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Hib Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Hib Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Hib Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Hib Vaccine Sales by Application (2021-2026) & (k units) Table 51. Global Hib Vaccine Sales by Application (2027-2032) & (k units) Table 52. Global Hib Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Hib Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Hib Vaccine Price by Application (2021-2026) & (US$/unit) Table 55. Global Hib Vaccine Price by Application (2027-2032) & (US$/unit) Table 56. Lanzhou Institute Company Information Table 57. Lanzhou Institute Business Overview Table 58. Lanzhou Institute Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Lanzhou Institute Hib Vaccine Product Portfolio Table 60. Lanzhou Institute Recent Development Table 61. Zhifei Bio Company Information Table 62. Zhifei Bio Business Overview Table 63. Zhifei Bio Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Zhifei Bio Hib Vaccine Product Portfolio Table 65. Zhifei Bio Recent Development Table 66. Sanofi Pasteur Company Information Table 67. Sanofi Pasteur Business Overview Table 68. Sanofi Pasteur Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Sanofi Pasteur Hib Vaccine Product Portfolio Table 70. Sanofi Pasteur Recent Development Table 71. Kangtai Bio Company Information Table 72. Kangtai Bio Business Overview Table 73. Kangtai Bio Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Kangtai Bio Hib Vaccine Product Portfolio Table 75. Kangtai Bio Recent Development Table 76. Watson Bio Company Information Table 77. Watson Bio Business Overview Table 78. Watson Bio Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Watson Bio Hib Vaccine Product Portfolio Table 80. Watson Bio Recent Development Table 81. Glaxosmithkline Company Information Table 82. Glaxosmithkline Business Overview Table 83. Glaxosmithkline Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Glaxosmithkline Hib Vaccine Product Portfolio Table 85. Glaxosmithkline Recent Development Table 86. Olin Bio Company Information Table 87. Olin Bio Business Overview Table 88. Olin Bio Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Olin Bio Hib Vaccine Product Portfolio Table 90. Olin Bio Recent Development Table 91. Bharat Biotech Company Information Table 92. Bharat Biotech Business Overview Table 93. Bharat Biotech Hib Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Bharat Biotech Hib Vaccine Product Portfolio Table 95. Bharat Biotech Recent Development Table 96. North America Hib Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Hib Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Hib Vaccine Sales by Type (2021-2026) & (k units) Table 99. North America Hib Vaccine Sales by Type (2027-2032) & (k units) Table 100. North America Hib Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 101. North America Hib Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 102. North America Hib Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Hib Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Hib Vaccine Sales by Application (2021-2026) & (k units) Table 105. North America Hib Vaccine Sales by Application (2027-2032) & (k units) Table 106. North America Hib Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 107. North America Hib Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 108. North America Hib Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. North America Hib Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 110. North America Hib Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 111. North America Hib Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 112. North America Hib Vaccine Sales by Country (2021-2026) & (k units) Table 113. North America Hib Vaccine Sales by Country (2027-2032) & (k units) Table 114. North America Hib Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 115. North America Hib Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 116. United States Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 117. Canada Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 118. Mexico Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 119. Europe Hib Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Hib Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Hib Vaccine Sales by Type (2021-2026) & (k units) Table 122. Europe Hib Vaccine Sales by Type (2027-2032) & (k units) Table 123. Europe Hib Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 124. Europe Hib Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 125. Europe Hib Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe Hib Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe Hib Vaccine Sales by Application (2021-2026) & (k units) Table 128. Europe Hib Vaccine Sales by Application (2027-2032) & (k units) Table 129. Europe Hib Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 130. Europe Hib Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 131. Europe Hib Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Hib Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. Europe Hib Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. Europe Hib Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 135. Europe Hib Vaccine Sales by Country (2021-2026) & (k units) Table 136. Europe Hib Vaccine Sales by Country (2027-2032) & (k units) Table 137. Europe Hib Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 138. Europe Hib Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 139. Germany Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 140. France Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 141. U.K. Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 142. Italy Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 143. Russia Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 144. Spain Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 145. Netherlands Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 146. Switzerland Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 147. Sweden Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 148. Poland Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 149. China Hib Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 150. China Hib Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 151. China Hib Vaccine Sales by Type (2021-2026) & (k units) Table 152. China Hib Vaccine Sales by Type (2027-2032) & (k units) Table 153. China Hib Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 154. China Hib Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 155. China Hib Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 156. China Hib Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 157. China Hib Vaccine Sales by Application (2021-2026) & (k units) Table 158. China Hib Vaccine Sales by Application (2027-2032) & (k units) Table 159. China Hib Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 160. China Hib Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 161. Asia Hib Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia Hib Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia Hib Vaccine Sales by Type (2021-2026) & (k units) Table 164. Asia Hib Vaccine Sales by Type (2027-2032) & (k units) Table 165. Asia Hib Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 166. Asia Hib Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 167. Asia Hib Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia Hib Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Hib Vaccine Sales by Application (2021-2026) & (k units) Table 170. Asia Hib Vaccine Sales by Application (2027-2032) & (k units) Table 171. Asia Hib Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 172. Asia Hib Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 173. Asia Hib Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia Hib Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Asia Hib Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Asia Hib Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 177. Asia Hib Vaccine Sales by Country (2021-2026) & (k units) Table 178. Asia Hib Vaccine Sales by Country (2027-2032) & (k units) Table 179. Asia Hib Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 180. Asia Hib Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 181. Japan Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 182. South Korea Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 183. India Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 184. Australia Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 185. Taiwan Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 186. Southeast Asia Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 187. SAMEA Hib Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 188. SAMEA Hib Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 189. SAMEA Hib Vaccine Sales by Type (2021-2026) & (k units) Table 190. SAMEA Hib Vaccine Sales by Type (2027-2032) & (k units) Table 191. SAMEA Hib Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 192. SAMEA Hib Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 193. SAMEA Hib Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 194. SAMEA Hib Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 195. SAMEA Hib Vaccine Sales by Application (2021-2026) & (k units) Table 196. SAMEA Hib Vaccine Sales by Application (2027-2032) & (k units) Table 197. SAMEA Hib Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 198. SAMEA Hib Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 199. SAMEA Hib Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. SAMEA Hib Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. SAMEA Hib Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. SAMEA Hib Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 203. SAMEA Hib Vaccine Sales by Country (2021-2026) & (k units) Table 204. SAMEA Hib Vaccine Sales by Country (2027-2032) & (k units) Table 205. SAMEA Hib Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 206. SAMEA Hib Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 207. Brazil Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 208. Argentina Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 209. Chile Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 210. Colombia Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 211. Peru Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Saudi Arabia Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Israel Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 214. UAE Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Turkey Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Iran Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Egypt Hib Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. Hib Vaccine Distributors List Table 221. Hib Vaccine Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. Hib Vaccine Image Figure 2. Global Hib Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hib Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hib Vaccine Image Figure 5. Multiple Seedlings Image Figure 6. Global Hib Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Hib Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Hib Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Hib Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Hib Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Hib Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Hib Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Hib Vaccine Sales (2021-2032) & (k units) Figure 16. Global Hib Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Hib Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Hib Vaccine Sales YoY (2021-2032) & (k units) Figure 19. Europe Hib Vaccine Sales YoY (2021-2032) & (k units) Figure 20. China Hib Vaccine Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Hib Vaccine Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Hib Vaccine Sales YoY (2021-2032) & (k units) Figure 23. Global Hib Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Hib Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Hib Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Hib Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Hib Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Hib Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Hib Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Hib Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Hib Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Hib Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Hib Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Hib Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Hib Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Hib Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Hib Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Hib Vaccine Sales Share by Type (2021-2032) Figure 40. North America Hib Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Hib Vaccine Sales Share by Application (2021-2032) Figure 42. North America Hib Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Hib Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Hib Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Hib Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Hib Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Hib Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Hib Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Hib Vaccine Sales Share by Country (2021-2032) Figure 50. China Hib Vaccine Revenue Share by Type (2021-2032) Figure 51. China Hib Vaccine Sales Share by Type (2021-2032) Figure 52. China Hib Vaccine Revenue Share by Application (2021-2032) Figure 53. China Hib Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Hib Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Hib Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Hib Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Hib Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Hib Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Hib Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Hib Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Hib Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Hib Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Hib Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Hib Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Hib Vaccine Sales Share by Country (2021-2032) Figure 66. Hib Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Hib Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Hib Vaccine
  • Multiple Seedlings
Applications
  • Hospital
  • Clinic
Companies covered
  • Lanzhou Institute
  • Zhifei Bio
  • Sanofi Pasteur
  • Kangtai Bio
  • Watson Bio
  • Glaxosmithkline
  • Olin Bio
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hib Vaccine Market by Type
  3. 1.2.1 Global Hib Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hib Vaccine
  5. 1.2.3 Multiple Seedlings
  6. 1.3 Hib Vaccine Market by Application
  7. 1.3.1 Global Hib Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Hib Vaccine Market Dynamics
  1. 2.1 Hib Vaccine Industry Trends
  2. 2.2 Hib Vaccine Industry Drivers
  3. 2.3 Hib Vaccine Industry Opportunities and Challenges
  4. 2.4 Hib Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Hib Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Hib Vaccine Revenue by Region
  3. 3.2.1 Global Hib Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hib Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Hib Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Hib Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Hib Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Hib Vaccine Sales by Region
  9. 3.4.1 Global Hib Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Hib Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Hib Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Hib Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Hib Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Hib Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Hib Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Hib Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hib Vaccine Sales by Manufacturers
  6. 4.2.1 Global Hib Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Hib Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Hib Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Hib Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Hib Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Hib Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Hib Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Hib Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Hib Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Hib Vaccine Tier 1, Tier 2, and Tier 3
5 Hib Vaccine Market by Type
  1. 5.1 Global Hib Vaccine Revenue by Type
  2. 5.1.1 Global Hib Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Hib Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Hib Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Hib Vaccine Sales by Type
  6. 5.2.1 Global Hib Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hib Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Hib Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Hib Vaccine Price by Type
6 Hib Vaccine Market by Application
  1. 6.1 Global Hib Vaccine Revenue by Application
  2. 6.1.1 Global Hib Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Hib Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Hib Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Hib Vaccine Sales by Application
  6. 6.2.1 Global Hib Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Hib Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Hib Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Hib Vaccine Price by Application
7 Company Profiles
  1. 7.1 Lanzhou Institute
  2. 7.1.1 Lanzhou Institute Company Information
  3. 7.1.2 Lanzhou Institute Business Overview
  4. 7.1.3 Lanzhou Institute Hib Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Lanzhou Institute Hib Vaccine Product Portfolio
  6. 7.1.5 Lanzhou Institute Recent Developments
  7. 7.2 Zhifei Bio
  8. 7.2.1 Zhifei Bio Company Information
  9. 7.2.2 Zhifei Bio Business Overview
  10. 7.2.3 Zhifei Bio Hib Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zhifei Bio Hib Vaccine Product Portfolio
  12. 7.2.5 Zhifei Bio Recent Developments
  13. 7.3 Sanofi Pasteur
  14. 7.3.1 Sanofi Pasteur Company Information
  15. 7.3.2 Sanofi Pasteur Business Overview
  16. 7.3.3 Sanofi Pasteur Hib Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Pasteur Hib Vaccine Product Portfolio
  18. 7.3.5 Sanofi Pasteur Recent Developments
  19. 7.4 Kangtai Bio
  20. 7.4.1 Kangtai Bio Company Information
  21. 7.4.2 Kangtai Bio Business Overview
  22. 7.4.3 Kangtai Bio Hib Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Kangtai Bio Hib Vaccine Product Portfolio
  24. 7.4.5 Kangtai Bio Recent Developments
  25. 7.5 Watson Bio
  26. 7.5.1 Watson Bio Company Information
  27. 7.5.2 Watson Bio Business Overview
  28. 7.5.3 Watson Bio Hib Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Watson Bio Hib Vaccine Product Portfolio
  30. 7.5.5 Watson Bio Recent Developments
  31. 7.6 Glaxosmithkline
  32. 7.6.1 Glaxosmithkline Company Information
  33. 7.6.2 Glaxosmithkline Business Overview
  34. 7.6.3 Glaxosmithkline Hib Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Glaxosmithkline Hib Vaccine Product Portfolio
  36. 7.6.5 Glaxosmithkline Recent Developments
  37. 7.7 Olin Bio
  38. 7.7.1 Olin Bio Company Information
  39. 7.7.2 Olin Bio Business Overview
  40. 7.7.3 Olin Bio Hib Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Olin Bio Hib Vaccine Product Portfolio
  42. 7.7.5 Olin Bio Recent Developments
  43. 7.8 Bharat Biotech
  44. 7.8.1 Bharat Biotech Company Information
  45. 7.8.2 Bharat Biotech Business Overview
  46. 7.8.3 Bharat Biotech Hib Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bharat Biotech Hib Vaccine Product Portfolio
  48. 7.8.5 Bharat Biotech Recent Developments
8 North America
  1. 8.1 North America Hib Vaccine Market Size by Type
  2. 8.1.1 North America Hib Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Hib Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Hib Vaccine Price by Type (2021-2032)
  5. 8.2 North America Hib Vaccine Market Size by Application
  6. 8.2.1 North America Hib Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Hib Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Hib Vaccine Price by Application (2021-2032)
  9. 8.3 North America Hib Vaccine Market Size by Country
  10. 8.3.1 North America Hib Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Hib Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Hib Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Hib Vaccine Market Size by Type
  2. 9.1.1 Europe Hib Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Hib Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Hib Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Hib Vaccine Market Size by Application
  6. 9.2.1 Europe Hib Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Hib Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Hib Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Hib Vaccine Market Size by Country
  10. 9.3.1 Europe Hib Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Hib Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Hib Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Hib Vaccine Market Size by Type
  2. 10.1.1 China Hib Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Hib Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Hib Vaccine Price by Type (2021-2032)
  5. 10.2 China Hib Vaccine Market Size by Application
  6. 10.2.1 China Hib Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Hib Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Hib Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hib Vaccine Market Size by Type
  2. 11.1.1 Asia Hib Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Hib Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Hib Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Hib Vaccine Market Size by Application
  6. 11.2.1 Asia Hib Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Hib Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Hib Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Hib Vaccine Market Size by Country
  10. 11.3.1 Asia Hib Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Hib Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Hib Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hib Vaccine Market Size by Type
  2. 12.1.1 SAMEA Hib Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Hib Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Hib Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Hib Vaccine Market Size by Application
  6. 12.2.1 SAMEA Hib Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Hib Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Hib Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Hib Vaccine Market Size by Country
  10. 12.3.1 SAMEA Hib Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Hib Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Hib Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Hib Vaccine Value Chain Analysis
  2. 13.1.1 Hib Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Hib Vaccine Production Mode & Process
  6. 13.2 Hib Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Hib Vaccine Distributors
  9. 13.2.3 Hib Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst